Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 68071-2053

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 68071-2053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (6871 2053 1)

The text is a product description of Ondansetron 4mg tablets manufactured by NuCare Pharmaceuticals, Inc. The tablets are oval-shaped, white/off-white and film-coated. Each tablet contains Ondansetron Hydrochloride USP, equivalent to 4mg of Ondansetron. The tablets are marked with 'F' on one side and '91' on the other side. The medication is used for the prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery, among others. The package includes ten tablets and should be kept out of reach of children. Possible side effects should be reported to a doctor or FDA at 1-800-FDA-1088. The tablets should be stored at a controlled temperature of 59-36°F.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.